Analysis: Excellent news – but too many questions are still unanswered
That’s the bad news. The good news is that evidence is steadily building to suggest popping a daily aspirin cuts the chances of getting and dying from cancer.
For us, a cancer charity, that’s not just good news, that’s excellent news. But we’re not yet issuing any recommendations about daily aspirin, because there are still unanswered questions about the benefits and risks associated with its long-term use. And we simply don’t know enough about who will benefit most from the drug.
Advertisement
Hide AdAdvertisement
Hide AdBut the research published yesterday is certainly some of the most compelling to show that aspirin – a cheap, readily available drug – could one day be an important tool in the fight against cancer.
We hope that on the back of this latest work, the government will start to think about developing some definitive advice about whether aspirin should be recommended more widely.
• Professor Peter Johnson is chief clinician of Cancer Research UK